The titration schedule printed on your medication's label looks official, but it's built for the average patient — and you might not be one. Staying at a dose step longer than the calendar says is one of the most common, most legitimate adjustments in GLP-1 treatment.
The standard schedule is a starting point, not a requirement
As covered in our guide on how titration schedules work, the standard step-up timeline for GLP-1 medications reflects what works for most people — not a fixed rule that applies uniformly. Slowing down titration, meaning staying at a given dose step longer than the standard schedule before increasing, is a common, clinically supported adjustment rather than a deviation from proper treatment.
Common reasons to slow down
- GI side effects that haven't settled by the time the next increase is due. If nausea, vomiting, or other symptoms covered in our GI side effects overview are still significant rather than easing, extending the current dose step gives your body more time to adjust before adding more.
- A pattern of side effects intensifying with each increase, suggesting you may be a slower responder to dose changes than the standard schedule assumes.
- Other health factors — a concurrent illness, a demanding period at work or in life where managing more intense side effects would be especially difficult, or other individual circumstances your prescriber factors into pacing.
- A deliberate choice, particularly relevant if you're pursuing a body recomposition goal rather than maximum-speed weight loss, where a more gradual pace can better match what your nutrition and training plan can support.